SPONSOR
Todd C. Lee MD MPH FIDSA
Total Trials
3
Recruiting
3
Phases
Phase 4, Phase 2, Phase 3
Conditions studied: Staphylococcus Aureus SepticemiaStaphylococcus Aureus BacteremiaS. Aureus BacteremiaS. Aureus Bloodstream InfectionStaphylococcus Aureus EndocarditisStaphylococcal SepsisPneumocystisPneumocystis PneumoniaPneumocystis Jirovecii InfectionPneumocystis Infections
Todd C. Lee MD MPH FIDSA is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bacteremia, S. Aureus Bacteremia, S. Aureus Bloodstream Infection.
The trial portfolio spans Phase 4, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Todd C. Lee MD MPH FIDSA
How many clinical trials has Todd C. Lee MD MPH FIDSA sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Todd C. Lee MD MPH FIDSA, of which 3 are actively recruiting participants. These trials cover conditions including Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bacteremia, S. Aureus Bacteremia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Todd C. Lee MD MPH FIDSA research focus on?
Todd C. Lee MD MPH FIDSA clinical trials span Staphylococcus Aureus Septicemia, Staphylococcus Aureus Bacteremia, S. Aureus Bacteremia, S. Aureus Bloodstream Infection, Staphylococcus Aureus Endocarditis, and additional conditions. The research pipeline includes Phase 4, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Todd C. Lee MD MPH FIDSA clinical trial?
To participate in a Todd C. Lee MD MPH FIDSA trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Todd C. Lee MD MPH FIDSA trials with current recruitment status updated daily.
Clinical Trials by Todd C. Lee MD MPH FIDSA
NCT06637332 Phase 4
Recruiting
Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
Staphylococcus Aureus Septicemia
NCT04886284 Phase 2
Recruiting
Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
Staphylococcus Aureus Bacteremia
NCT04851015 Phase 3
Recruiting
Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia
Pneumocystis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology